Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On May 25, 2023, Finch Therapeutics Group, Inc. (the "Company") entered into a
consulting agreement with its former Chief Executive Officer, Mark Smith (the
"Consulting Agreement"). Pursuant to the Consulting Agreement, Dr. Smith is
engaged to provide advisory services to the Company in exchange for cash
consideration at an hourly rate and eligible to receive performance-based cash
payments. The performance-based payments, in a maximum aggregate amount of
$150,000, are payable based on the achievement of designated metrics related to
critical corporate objectives, following a determination by the Compensation
Committee of the Company's Board of Directors that such metric has been
satisfied.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses